Rosalind Advisors »

Neuraxis shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Neuraxis (NRXS) shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Neuraxis

Tip: Access up to 7 years of quarterly data

All positions including Neuraxis held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuraxis by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.0M 286k 3.63

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Savara (SVRA)
Fennec Pharmaceuticals (FENC)
Xeris Pharmaceuticals (XERS)
Miragen Therapeutics (VRDN)
Mediwound Shs New (MDWD)
Verastem Com New (VSTM)
Replimune Group (REPL)
Atyr Pharma (ATYR)
Cybin Com New (HELP)
Eyepoint Pharmaceuticals Com New (EYPT)
Cg Oncology (CGON)
Cytokinetics Com New (CYTK)
X4 Pharmaceuticals Com New (XFOR)
Mind Medicine Mindmed Com New (MNMD)

View all positions for Rosalind Advisors

Top funds holding Neuraxis

AIGH Capital Management
Rosalind Advisors
Money Concepts Capital Corp
Vanguard Group
Parsons Capital Management
Geode Capital Management
UBS Group
Citadel Advisors
State Street Corporation
Northern Trust
Wealthcare Advisory Partners
Royal Bank of Canada
XTX Topco
LPL Financial
Tower Research Capital

View all funds holding Neuraxis